🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Repaglinide - Medicines in Ireland

42 authorised products containing Repaglinide, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
Showing 42 authorised medicines
MedicineActive substanceLicence holderStatus
Enyglid 0.5 mg tablets
EU/1/09/580/1-6
 Repaglinide KRKA, d.d., Novo mesto —
Enyglid 1 mg tablets
EU/1/09/580/7-12
 Repaglinide KRKA, d.d., Novo mesto —
Enyglid 2 mg tablets
EU/1/09/580/13-18
 Repaglinide KRKA, d.d., Novo mesto —
NovoNorm 0.5 mg tablets
EU/1/98/076/004
 Repaglinide Novo Nordisk A/S —
NovoNorm 0.5 mg tablets
EU/1/98/076/005
 Repaglinide Novo Nordisk A/S —
NovoNorm 0.5 mg tablets
EU/1/98/076/006
 Repaglinide Novo Nordisk A/S —
NovoNorm 0.5 mg tablets
EU/1/98/076/007
 Repaglinide Novo Nordisk A/S —
NovoNorm 1 mg tablets
EU/1/98/076/011
 Repaglinide Novo Nordisk A/S —
NovoNorm 1 mg tablets
EU/1/98/076/012
 Repaglinide Novo Nordisk A/S —
NovoNorm 1 mg tablets
EU/1/98/076/013
 Repaglinide Novo Nordisk A/S —
NovoNorm 1 mg tablets
EU/1/98/076/014
 Repaglinide Novo Nordisk A/S —
NovoNorm 2 mg tablets
EU/1/98/076/018
 Repaglinide Novo Nordisk A/S —
NovoNorm 2 mg tablets
EU/1/98/076/019
 Repaglinide Novo Nordisk A/S —
NovoNorm 2 mg tablets
EU/1/98/076/020
 Repaglinide Novo Nordisk A/S —
NovoNorm 2 mg tablets
EU/1/98/076/021
 Repaglinide Novo Nordisk A/S —
Prandin
EU/1/00/162/002
 Repaglinide Novo Nordisk A/S —
Prandin
EU/1/00/162/003
 Repaglinide Novo Nordisk A/S —
Prandin
EU/1/00/162/004
 Repaglinide Novo Nordisk A/S —
Prandin
EU/1/00/162/005
 Repaglinide Novo Nordisk A/S —
Prandin
EU/1/00/162/006
 Repaglinide Novo Nordisk A/S —
Prandin
EU/1/00/162/007
 Repaglinide Novo Nordisk A/S —
Prandin
EU/1/00/162/008
 Repaglinide Novo Nordisk A/S —
Prandin
EU/1/00/162/009
 Repaglinide Novo Nordisk A/S —
Prandin
EU/1/00/162/010
 Repaglinide Novo Nordisk A/S —
Prandin
EU/1/00/162/011
 Repaglinide Novo Nordisk A/S —
Prandin
EU/1/00/162/012
 Repaglinide Novo Nordisk A/S —
Prandin
EU/1/00/162/013
 Repaglinide Novo Nordisk A/S —
Prandin
EU/1/00/162/014
 Repaglinide Novo Nordisk A/S —
Prandin
EU/1/00/162/015
 Repaglinide Novo Nordisk A/S —
Prandin
EU/1/00/162/016
 Repaglinide Novo Nordisk A/S —
Prandin
EU/1/00/162/017
 Repaglinide Novo Nordisk A/S —
Prandin
EU/1/00/162/018
 Repaglinide Novo Nordisk A/S —
PRANDIN
EU/1/00/162/001
 Repaglinide Novo Nordisk A/S —
Repaglinide Accord 0.5 mg tablets
EU/1/11/743/001-005
 Repaglinide Accord Healthcare S.L.U. —
Repaglinide Accord 1 mg tablets
EU/1/11/743/006-010
 Repaglinide Accord Healthcare S.L.U. —
Repaglinide Accord 2 mg tablets
EU/1/11/743/011-015
 Repaglinide Accord Healthcare S.L.U. —
Repaglinide Krka 0.5 mg tablets
EU/1/09/579/1-6
 Repaglinide KRKA, d.d., Novo mesto —
Repaglinide Krka 1 mg tablets
EU/1/09/579/7-12
 Repaglinide KRKA, d.d., Novo mesto —
Repaglinide Krka 2 mg tablets
EU/1/09/579/13-18
 Repaglinide KRKA, d.d., Novo mesto —
Repaglinide Teva 0.5 mg Tablet
EU/1/09/530/1-5
 Repaglinide Teva Pharma B.V. —
Repaglinide Teva 1 mg Tablet
EU/1/09/530/6-10
 Repaglinide Teva Pharma B.V. —
Repaglinide Teva 2 mg Tablet
EU/1/09/530/11-15
 Repaglinide Teva Pharma B.V. —
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.